{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-153034","form_type":"8-K","ticker":"SPRO","cik":"0001701108","company_name":"Spero Therapeutics, Inc.","filed_at":"2024-06-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.652272+00:00","generated_at":"2026-06-01T06:51:17.092326+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Spero Therapeutics shareholders approve 3M share increase for 2017 stock plan","bullets":["Stockholders approved amendment to 2017 Stock Incentive Plan, adding 3,000,000 authorized shares.","All three Class I director nominees (Scott Jackson, John C. Pottage Jr., Cynthia Smith) were reelected.","Ratification of PricewaterhouseCoopers as auditor for FY2024 passed with 36.6M votes for.","Advisory vote on executive compensation approved (23.9M for, 442k against).","Quorum of 68.23% of outstanding shares present at annual meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-153034","json":"https://secwatch.observer/filing/0001193125-24-153034.json","markdown":"https://secwatch.observer/filing/0001193125-24-153034.md","text":"https://secwatch.observer/filing/0001193125-24-153034.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1701108/000119312524153034/0001193125-24-153034-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1701108/000119312524153034/d842476d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T06:51:17.092326+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}